MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils

Gut

Volumn 66, Issue 4, 2017, Pages 705-715

  Li, Man ^a,b   He, Yong ^a   Zhou, Zhou ^a   Ramirez, Teresa ^a   Gao, Yueqiu ^b   Gao, Yanhang ^a   Ross, Ruth A ^c   Cao, Haixia ^a   Cai, Yan ^a   Xu, Mingjiang ^a   Feng, Dechun ^a   Zhang, Ping ^d   Liangpunsakul, Suthat ^c,e,f   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Northeast Ohio Medical University   (United States)

^e INDIANA UNIVERSITY   (United States)

^f RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; INTERLEUKIN 6; MICRORNA 223; PROTEIN P47; PROTEIN P47PHOX; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ALCOHOL; BILIRUBIN; CENTRAL DEPRESSANT AGENT; MICRORNA; MIRN223 MICRORNA, HUMAN; MIRN223 MICRORNA, MOUSE; NEUTROPHIL CYTOSOLIC FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BINGE DRINKING; CELL FUNCTION; CONTROLLED STUDY; CORRELATIONAL STUDY; DIETARY INTAKE; DISEASE MARKER; DOWN REGULATION; EXPERIMENTAL LIVER INJURY; FEMALE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RNA ANALYSIS; ALCOHOL LIVER DISEASE; ANIMAL; BLOOD; C57BL MOUSE; CASE CONTROL STUDY; COMPLICATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; UPREGULATION; YOUNG ADULT;

ADULT; ALANINE TRANSAMINASE; ALCOHOLISM; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BINGE DRINKING; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DOWN-REGULATION; ETHANOL; FEMALE; HUMANS; INTERLEUKIN-6; LIVER DISEASES, ALCOHOLIC; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MIDDLE AGED; NADPH OXIDASE; NEUTROPHILS; REACTIVE OXYGEN SPECIES; UP-REGULATION; YOUNG ADULT;

EID: 84988952820     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-311861     Document Type: Article

References (47)

1. Dunn W, Shah VH. Pathogenesis of alcoholic liver disease. Clin Liver Dis 2016;20:445-56.
2. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011;141:1572-85.
3. Nagy LE, Ding WX, Cresci G, et al. Linking pathogenic mechanisms of alcoholic liver disease with clinical phenotypes. Gastroenterology 2016;150:1756-68.
4. Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology 2015;148:30-6.
5. Gao B, Tsukamoto H. Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe? Gastroenterology 2016;150:1704-9.
6. Wang HJ, Gao B, Zakhari S, et al. Inflammation in alcoholic liver disease. Annu Rev Nutr 2012;32:343-68.
7. Bertola A, Park O, Gao B. Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin. Hepatology 2013;58:1814-23.
8. Xu MJ, Cai Y, Wang H, et al. Fat-specific protein 27/CIDEC promotes development of alcoholic steatohepatitis in mice and humans. Gastroenterology 2015;149:1030-41.e6.
9. Mandrekar P, Bataller R, Tsukamoto H, et al. Alcoholic hepatitis: translational approaches to develop targeted therapies. Hepatology Published Online First: 15 Apr 2016. doi: 10.1002/hep.28530
10. Lazaro R, Wu R, Lee S, et al. Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice. Hepatology 2015;61:129-40.
11. Maricic I, Sheng H, Marrero I, et al. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice. Hepatology 2015;61:1357-69.
12. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007;35:757-66.
13. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245-313.
14. Jiang JX, Torok NJ. NADPH oxidases in chronic liver diseases. Adv Hepatol 2014;2014:pii: 742931.
15. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 2002;27:23-7.
16. Liang S, Kisseleva T, Brenner DA. The Role of NADPH Oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts. Front Physiol 2016;7:17.
17. Paik YH, Kim J, Aoyama T, et al. Role of NADPH oxidases in liver fibrosis. Antioxid Redox Signal 2014;20:2854-72.
18. Wang XW, Heegaard NH, Orum H. MicroRNAs in liver disease. Gastroenterology 2012;142:1431-43.
19. Matsuura K, Giorgi V, Schechterly C, et al. Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C. Hepatology 2016;64:732-45.
20. Pirola CJ, Fernandez Gianotti T, Castano GO, et al. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut 2015;64:800-12.
21. Jung KH, Zhang J, Zhou C, et al. Differentiation therapy for hepatocellular carcinoma: multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis. Hepatology 2016;63:864-79.
22. Szabo G, Satishchandran A. MicroRNAs in alcoholic liver disease. Semin Liver Dis 2015;35:36-42.
23. McDaniel K, Herrera L, Zhou T, et al. The functional role of microRNAs in alcoholic liver injury. J Cell Mol Med 2014;18:197-207.
24. Chen YP, Jin X, Kong M, et al. Pattern of microRNA expression associated with different stages of alcoholic liver disease in rat models. Mol Med Rep 2014;10:1195-204.
25. Dolganiuc A, Petrasek J, Kodys K, et al. MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res 2009;33:1704-10.
26. Meng F, Glaser SS, Francis H, et al. Epigenetic regulation of miR-34a expression in alcoholic liver injury. Am J Pathol 2012;181:804-17.
27. Bala S, Csak T, Saha B, et al. The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis. J Hepatol 2016;64:1378-87.
28. Stickel F, Dubuquoy L. MicroRNA in alcoholic hepatitis: implications for pathophysiology and treatment. Gut 2016;65:1400-1.
29. Blaya D, Coll M, Rodrigo-Torres D, et al. Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation. Gut 2016;65:1535-45.
30. Gantier MP. The not-so-neutral role of microRNAs in neutrophil biology. J Leukoc Biol 2013;94:575-83.
31. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression Atlas based on small RNA library sequencing. Cell 2007;129:1401-14.
32. Ward JR, Heath PR, Catto JW, et al. Regulation of neutrophil senescence by microRNAs. PLoS ONE 2011;6:e15810.
33. Bertola A, Mathews S, Ki SH, et al. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 2013;8:627-37.
34. Hong F, Radaeva S, Pan HN, et al. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 2004;40:933-41.
35. Kleniewska P, Piechota A, Skibska B, et al. The NADPH oxidase family and its inhibitors. Arch Immunol Ther Exp (Warsz) 2012;60:277-94.
36. El-Benna J, Dang PM, Gougerot-Pocidalo MA, et al. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med 2009;41:217-25.
37. Harraz MM, Eacker SM, Wang X, et al. MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proc Natl Acad Sci USA 2012;109:18962-7.
38. Dorhoi A, Iannaccone M, Farinacci M, et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J Clin Invest 2013;123:4836-48.
39. Roh YS, Zhang B, Loomba R, et al. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. Am J Physiol Gastrointest Liver Physiol 2015;309:G30-41.
40. Wang S, Ni HM, Dorko K, et al. Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury. Oncotarget 2016;7:17681-98.
41. Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008;451:1125-9.
42. Kono H, Rusyn I, Yin M, et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 2000;106:867-72.
43. Xi X, Zhang C, Han W, et al. MicroRNA-223 is upregulated in active tuberculosis patients and inhibits apoptosis of macrophages by targeting FOXO3. Genet Test Mol Biomarkers 2015;19:650-6.
44. Haoues M, Refai A, Mallavialle A, et al. Forkhead box O3 (FOXO3) transcription factor mediates apoptosis in BCG-infected macrophages. Cell Microbiol 2014;16:1378-90.
45. Zhuang G, Meng C, Guo X, et al. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012;125:2892-903.
46. Ying W, Tseng A, Chang RC, et al. MicroRNA-223 is a crucial mediator of PPARgamma-regulated alternative macrophage activation. J Clin Invest 2015;125:4149-59.
47. Qadir XV, Chen W, Han C, et al. miR-223 deficiency protects against fas-induced hepatocyte apoptosis and liver injury through targeting insulin-like growth factor 1 receptor. Am J Pathol 2015;185:3141-51.